Table 2.
Participant Demographics
| Pre-Pandemic Negative Controls | PCR-Negative Symptomatic Mild | PCR-Positive Symptomatic Mild | PCR-Positive Symptomatic Moderate | PCR-Positive Symptomatic Severe | |
|---|---|---|---|---|---|
| N | 60 | 30 | 31 | 59 | 50 |
| N (independent) | 60 | 30 | 31 | 30 | 30 |
| Average Age (yrs) | 41.17 | 56.63 | 56.43 | ||
| Age Range (yrs) | 19–67 | 22–80 | 22–89 | ||
| Females | 22 | 15 | 12 | ||
| Males | 9 | 15 | 18 | ||
| Race: White | 16 | 4 | 6 | ||
| Race: Black or African American | 4 | 19 | 13 | ||
| Race: Hispanic or Latino | 3 | 4 | 8 | ||
| Race: Asian | 2 | 2 | 2 | ||
| Race: Other/Not Documented | 4 | 1 | 1 | ||
| Death | 0 | 2 | 9 |
Available demographic information across disease severities, including age, sex, race/ethnicity, and mortality outcomes.
**
No demographic information, including age, sex, or race/ethnicity were available for the pre-pandemic negative control group or PCR-negative mild group due to the retrospective nature of this study and participant sample records.